ctla4 (Bio X Cell)
96
Structured Review
Bio X Cell
ctla4
Ctla4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 409 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ctla4/InVivoMAb+anti-mouse+CTLA-4/10__1080_slash_2162402x__2026__2643494-41-18-25
Average 96 stars, based on 409 article reviews
Ctla4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 409 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ctla4/InVivoMAb+anti-mouse+CTLA-4/10__1080_slash_2162402x__2026__2643494-41-18-25
Average 96 stars, based on 409 article reviews
ctla4 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Control:Article Title: Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancers Article Snippet: .. The following antibodies and doses were used: anti-PD1 (250 ug, Bio X Cell, BE0146, RRID:AB_10949053), Saline:Article Title: 89 Zr-anti-CD8 immunoPET visualizes heterogeneous intratumoral CD8 + immune responses to treatment with radiation and anti-CTLA4. Article Snippet: Orthotopic tumor implantation and treatment For orthotopic injections, tumor cells were suspended in 50 μl of Matrigel matrix (Corning Cat # 356237) and Hanks’ Balanced Salt Solution (HBSS, Corning Cat # 21-022-CV). .. Article Title: 89 Zr-anti-CD8 immunoPET visualizes heterogeneous intratumoral CD8 + immune responses to treatment with radiation and anti-CTLA4 Article Snippet: For orthotopic injections, tumor cells were suspended in 50 μl of Matrigel matrix (Corning Cat # 356237) and Hanks’ Balanced Salt Solution (HBSS, Corning Cat # 21-022-CV). .. Mouse Assay:Article Title: Manipulation of meningeal lymphatic vasculature for brain and CNS tumor therapy Article Snippet: .. Mice were given either only intracranial tumors (IC) or a flank tumor and intracranial tumor (FT) and were treated with GFP/VEGFC-mRNA on day 7 and anti-PD1 (RMP1-14), |